Organ System Toxicity

Many drugs cause harm by injuring specific organs -- most prominently the liver and kidneys, but also the heart, nervous system, and others. Organ-system toxicity is studied by the mechanisms through which a circulating drug or its metabolites damage particular tissues, why those organs are preferentially exposed, and how the resulting injury is recognised. The liver and kidney are central because of their roles in drug metabolism and excretion.

Definition

Organ system toxicity is drug-induced damage that is concentrated in one or more specific organs or tissues, arising when a drug or its metabolites disrupt cellular function in those targets through mechanisms such as reactive-metabolite formation, mitochondrial injury, oxidative stress, or pharmacological accumulation.

Scope

The topic surveys target-organ toxicity in pharmacology, with emphasis on drug-induced liver injury and nephrotoxicity and reference to cardiotoxicity and other patterns. It describes mechanisms -- reactive metabolites, mitochondrial injury, oxidative stress, and accumulation -- and the distinction between intrinsic (dose-dependent) and idiosyncratic injury. It is an educational reference, not clinical guidance.

Core questions

• Why are the liver and kidney especially vulnerable to drug toxicity?
• How does intrinsic (predictable) toxicity differ from idiosyncratic toxicity?
• What cellular mechanisms underlie drug-induced liver and kidney injury?
• How is organ toxicity detected and attributed to a drug?

Key concepts

• Hepatotoxicity / drug-induced liver injury (DILI)
• Nephrotoxicity
• Cardiotoxicity
• Intrinsic (dose-dependent) toxicity
• Idiosyncratic toxicity
• Reactive metabolites
• Mitochondrial injury and oxidative stress
• Target-organ exposure and accumulation

Mechanisms

Organ toxicity reflects both why a tissue is exposed and how it is injured. The liver receives drugs first-pass from the gut and generates reactive metabolites during biotransformation, which can deplete protective molecules such as glutathione, bind cellular proteins, injure mitochondria, and trigger oxidative stress and cell death; injury may be intrinsic and dose-predictable or idiosyncratic and rare (Yuan & Kaplowitz, 2013). The kidney concentrates and excretes drugs and is exposed to high luminal and interstitial drug concentrations, predisposing it to tubular toxicity, oxidative damage, and crystal or obstructive injury (Wu & Huang, 2018). Across organs, the intrinsic-versus-idiosyncratic distinction parallels the Type A / Type B framework for adverse reactions (Edwards & Aronson, 2000).

Clinical relevance

Drug-induced liver injury is a leading cause of acute liver failure and of drugs being withdrawn from the market, and nephrotoxicity is a frequent contributor to hospital-acquired kidney injury. Understanding which organs are at risk and by what mechanism is part of evidence appraisal and pharmacovigilance. This entry explains those mechanisms as reference material and does not provide monitoring or treatment instructions.

Epidemiology

The frequency of organ toxicity varies widely by drug: intrinsic hepatotoxins such as paracetamol in overdose produce predictable, dose-related injury, whereas idiosyncratic drug-induced liver injury is rare per exposure but, summed across many drugs, is a major cause of serious liver injury (Yuan & Kaplowitz, 2013). Nephrotoxicity is similarly drug- and context-dependent (Wu & Huang, 2018).

Evidence & guidelines

Mechanistic understanding comes from toxicology and hepatology/nephrology reviews (Yuan & Kaplowitz, 2013; Wu & Huang, 2018), while attribution of injury to a drug relies on causality-assessment methods and pharmacovigilance rather than a single diagnostic test. The intrinsic/idiosyncratic and Type A/Type B frameworks supply the conceptual scaffold (Edwards & Aronson, 2000).

History

Recognition that specific organs are preferential targets of drug toxicity grew with twentieth-century pharmacology and toxicology, and paracetamol hepatotoxicity became a defining model of reactive-metabolite-mediated, glutathione-dependent injury. Drug-induced liver injury has repeatedly driven post-marketing withdrawals, sharpening attention to mechanism-based prediction (Yuan & Kaplowitz, 2013). Nephrotoxicity research has paralleled this with a focus on tubular handling and biomarkers (Wu & Huang, 2018).

Debates

Can idiosyncratic organ toxicity be predicted before it occurs?

Intrinsic, dose-dependent toxicity is reproducible and predictable, but idiosyncratic injury is rare, host-dependent, and poorly captured by standard preclinical testing, so whether and how it can be anticipated remains an active question in drug safety science.

Key figures

• Neil Kaplowitz
• Lily Yuan
• Hartmut Jaeschke
• I. Ralph Edwards
• Jeffrey K. Aronson

Seminal works

• yuan-kaplowitz-2013
• wu-2018

Frequently asked questions

Why are the liver and kidney the organs most often damaged by drugs?

The liver is the main site of drug metabolism and is exposed to drugs and their reactive metabolites first, while the kidney filters and concentrates drugs for excretion and so encounters high local concentrations. Both functions place these organs at the front line of drug exposure.

What is the difference between intrinsic and idiosyncratic toxicity?

Intrinsic toxicity is dose-dependent, reproducible, and predictable from the drug -- as with paracetamol overdose -- whereas idiosyncratic toxicity is rare, largely independent of dose, depends on host factors, and is difficult to anticipate.